Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$463K Sell
1,278
-45
-3% -$15.4K 0.14% 186
2026
Q1
$465K Buy
1,323
+46
+4% +$16.4K 0.15% 178
2025
Q4
$418K Hold
1,277
– – 0.14% 171
2025
Q3
$360K Buy
+1,277
New +$370K 0.12% 187

Other funds holding AMGN

Tred Avon Family Wealth's AMGN Position: Q2 2026 in Review

Tred Avon Family Wealth reduced its Amgen (AMGN) stake by 3.4% in Q2 2026, selling an estimated $15.4K and leaving 1,278 shares worth $463K. The position accounts for 0.14% of the portfolio, ranked #186.

Tred Avon Family Wealth first reported a position in AMGN in Q3 2025 and has held it in 4 quarters since. The position peaked at $465K in Q1 2026. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Tred Avon Family Wealth held 1,278 shares of Amgen worth $463K as of Q2 2026.
  • Tred Avon Family Wealth sold 45 Amgen shares in Q2 2026, an estimated $15.4K.
  • Amgen made up 0.14% of Tred Avon Family Wealth's portfolio in Q2 2026, its #186 holding.
  • Tred Avon Family Wealth first reported a position in Amgen in Q3 2025 and has held it in 4 quarters since.
  • Tred Avon Family Wealth's Amgen position peaked at $465K in Q1 2026.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Tred Avon Family Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.